STRATA Skin Sciences to Participate in the Lytham Partners Summer 2022 Investor Conference

Rhea-AI Summary

STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leader in dermatologic medical technology, will participate in the Lytham Partners Summer 2022 Investor Conference on June 21-22, 2022. This virtual event will include one-on-one meetings with management, aimed at enhancing investor engagement.

STRATA focuses on innovative treatment solutions for various skin conditions, including psoriasis and acne, through products like the XTRAC and TheraClear systems. The company’s unique business model emphasizes Direct to Consumer advertising to grow its partner dermatology clinics.

HORSHAM, Pa., June 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in the Lytham Partners Summer 2022 Investor Conference taking place virtually on June 21-22, 2022.

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register at www.lythampartners.com/summer2022invreg/.

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the in-office treatment of dermatologic conditions. Its products include the XTRAC®, XTRAC Momentum™ 1.0 and Pharos® excimer lasers, VTRAC® lamp systems, and TheraClear treatment system utilized in the treatment of psoriasis, vitiligo, acne and various other skin conditions.

The Company’s proprietary XTRAC, XTRAC Momentum™ 1.0 and Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. The technology is covered by multiple patents. Additionally, STRATA’s recently acquired assets related to Theravant Corporation’s TheraClear system allows the company to expand into the U.S. acne care market.

STRATA’s unique business model in the U.S. leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

Investor Contact
Jack Droogan
(203) 585-4140
ir@strataskin.com

FAQ

When will STRATA Skin Sciences participate in the Lytham Partners Summer 2022 Investor Conference?

STRATA Skin Sciences will participate in the Lytham Partners Summer 2022 Investor Conference on June 21-22, 2022.

What products does STRATA Skin Sciences offer for dermatologic conditions?

STRATA Skin Sciences offers products like the XTRAC, XTRAC Momentum 1.0, Pharos lasers, VTRAC lamp systems, and the TheraClear treatment system.

How does STRATA Skin Sciences engage with investors?

STRATA Skin Sciences engages with investors through virtual one-on-one meetings during investor conferences.

What market does STRATA Skin Sciences expand into with the TheraClear system?

STRATA Skin Sciences is expanding into the U.S. acne care market with the recently acquired TheraClear system.

What is the focus of STRATA Skin Sciences in the medical technology sector?

STRATA Skin Sciences focuses on developing and marketing innovative products for the treatment of dermatologic conditions.